Suppr超能文献

急性呼吸窘迫综合征的持久影响。

The long-lasting effects of the acute respiratory distress syndrome.

机构信息

Division of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.

出版信息

Expert Rev Respir Med. 2020 Jun;14(6):577-586. doi: 10.1080/17476348.2020.1743182. Epub 2020 Mar 17.

Abstract

: Acute respiratory distress syndrome (ARDS) is a severe form of acute lung injury common in critically ill patients and characterized by significant morbidity and mortality. It frequently manifests long-lasting effects beyond hospitalization, from cognitive impairment to physical weakness.: Several complications of ARDS have been identified in patients after hospital discharge. The authors conducted literature searches to identify observational studies, randomized clinical trials, systematic reviews, and guidelines. A summary of is presented here to outline the sequelae of ARDS and their risk factors with a focus on the limited but growing research into possible therapies. Long term sequelae of ARDS commonly identified in the literature include long-term cognitive impairment, psychological morbidities, neuromuscular weakness, pulmonary dysfunction, and ongoing healthcare utilization with reduced quality of life.: Given the public health significance of long-term complications following ARDS, the development of new therapies for prevention and treatment is of vital importance. Furthering knowledge of the pathophysiology of these impairments will provide a framework to develop new therapeutic targets to fuel future clinical trials in this area of critical care medicine.

摘要

急性呼吸窘迫综合征(ARDS)是一种严重的急性肺损伤,常见于重症患者,其特点是发病率和死亡率高。它经常在住院后产生持久的影响,从认知障碍到身体虚弱。

在出院后,患者出现了几种 ARDS 并发症。作者进行了文献检索,以确定观察性研究、随机临床试验、系统评价和指南。这里概述了 ARDS 的后遗症及其危险因素,重点介绍了对可能治疗方法的有限但不断增加的研究。文献中常见的 ARDS 长期后遗症包括长期认知障碍、心理病态、神经肌肉无力、肺功能障碍以及持续的医疗保健利用,生活质量降低。

鉴于 ARDS 后长期并发症的公共卫生意义,开发预防和治疗这些并发症的新疗法至关重要。深入了解这些损伤的病理生理学将为开发新的治疗靶点提供框架,以推动该重症监护医学领域的未来临床试验。

相似文献

1
The long-lasting effects of the acute respiratory distress syndrome.
Expert Rev Respir Med. 2020 Jun;14(6):577-586. doi: 10.1080/17476348.2020.1743182. Epub 2020 Mar 17.
2
Can we optimize long-term outcomes in acute respiratory distress syndrome by targeting normoxemia?
Ann Am Thorac Soc. 2014 May;11(4):613-8. doi: 10.1513/AnnalsATS.201401-001PS.
3
Acute Respiratory Distress Syndrome: Etiology, Pathogenesis, and Summary on Management.
J Intensive Care Med. 2020 Aug;35(8):723-737. doi: 10.1177/0885066619855021. Epub 2019 Jun 17.
4
Improving management of ARDS: uniting acute management and long-term recovery.
Crit Care. 2024 Feb 23;28(1):58. doi: 10.1186/s13054-024-04810-9.
6
Acute Respiratory Distress Syndrome: Diagnosis and Management.
Am Fam Physician. 2020 Jun 15;101(12):730-738.
8
Emerging drugs for treating the acute respiratory distress syndrome.
Expert Opin Emerg Drugs. 2019 Mar;24(1):29-41. doi: 10.1080/14728214.2019.1591369. Epub 2019 Mar 18.
9
The fibroproliferative response in acute respiratory distress syndrome: mechanisms and clinical significance.
Eur Respir J. 2014 Jan;43(1):276-85. doi: 10.1183/09031936.00196412. Epub 2013 Mar 21.

引用本文的文献

2
Carbonic anhydrase IX promotes acute lung injury and mortality in females during metabolic acidosis and pneumonia.
Am J Physiol Lung Cell Mol Physiol. 2025 Aug 1;329(2):L266-L281. doi: 10.1152/ajplung.00331.2024. Epub 2025 Jul 7.
5
An interpretable machine learning model for predicting mortality risk in adult ICU patients with acute respiratory distress syndrome.
Front Med (Lausanne). 2025 Apr 25;12:1580345. doi: 10.3389/fmed.2025.1580345. eCollection 2025.
6
Weathering the Storm: How Age and Biologics Influence the COVID-19 Cytokine Surge.
Pathogens. 2025 Apr 3;14(4):346. doi: 10.3390/pathogens14040346.
8
Longitudinal recovery trajectories and ventilatory modalities in COVID-19 acute respiratory distress syndrome survivors.
ERJ Open Res. 2025 Apr 7;11(2). doi: 10.1183/23120541.00770-2024. eCollection 2025 Mar.
9
Targeting mTOR in myeloid cells prevents infection-associated inflammation.
iScience. 2025 Mar 4;28(4):112163. doi: 10.1016/j.isci.2025.112163. eCollection 2025 Apr 18.

本文引用的文献

1
Association between Adherence to Recommended Care and Outcomes for Adult Survivors of Sepsis.
Ann Am Thorac Soc. 2020 Jan;17(1):89-97. doi: 10.1513/AnnalsATS.201907-514OC.
3
Randomized Clinical Trial of an ICU Recovery Pilot Program for Survivors of Critical Illness.
Crit Care Med. 2019 Oct;47(10):1337-1345. doi: 10.1097/CCM.0000000000003909.
4
Long-term neurocognitive outcome is not worsened by of the use of venovenous ECMO in severe ARDS patients.
Ann Intensive Care. 2019 Jul 16;9(1):82. doi: 10.1186/s13613-019-0556-1.
6
Cognitive decline after elective and nonelective hospitalizations in older adults.
Neurology. 2019 Feb 12;92(7):e690-e699. doi: 10.1212/WNL.0000000000006918. Epub 2019 Jan 11.
7
Latent class analysis of ARDS subphenotypes: a secondary analysis of the statins for acutely injured lungs from sepsis (SAILS) study.
Intensive Care Med. 2018 Nov;44(11):1859-1869. doi: 10.1007/s00134-018-5378-3. Epub 2018 Oct 5.
10
The Incremental Burden of Acute Respiratory Distress Syndrome: Long-term Follow-up of a Population-Based Nested Case-Control Study.
Mayo Clin Proc. 2018 Apr;93(4):445-452. doi: 10.1016/j.mayocp.2017.11.025. Epub 2018 Mar 1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验